The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) Post author:Sam Post published:September 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA's Has Big Plans to Get Drugs Approved Faster, Tackle Drug Development Costs September 11, 2017 AstraZeneca PLC CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo July 20, 2017 Why Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update February 9, 2017
AstraZeneca PLC CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo July 20, 2017
Why Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update February 9, 2017